<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Devonian Health Group Inc — News on 6ix</title>
<link>https://6ix.com/company/devonian-health-group-inc</link>
<description>Latest news and press releases for Devonian Health Group Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 25 Mar 2026 20:22:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/devonian-health-group-inc" rel="self" type="application/rss+xml" />
<item>
<title>Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-inc-reports-financial-and-operating-results-of-its-three-and-six-months-ended-january-31-2026</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-inc-reports-financial-and-operating-results-of-its-three-and-six-months-ended-january-31-2026</guid>
<pubDate>Wed, 25 Mar 2026 20:22:00 GMT</pubDate>
<description>Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months En...</description>
</item>
<item>
<title>Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-human-liver-on-a-chip-data-demonstrating-disease-relevant-modulation-of-mash-by-thykaminetm-with-dose-dependent-anti-fibrotic-and-anti-inflammatory-effects</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-human-liver-on-a-chip-data-demonstrating-disease-relevant-modulation-of-mash-by-thykaminetm-with-dose-dependent-anti-fibrotic-and-anti-inflammatory-effects</guid>
<pubDate>Thu, 19 Feb 2026 14:00:00 GMT</pubDate>
<description>Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by ...</description>
</item>
<item>
<title>Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-advances-thykaminetm-patent-strategy-with-proprietary-fingerprint-and-robust-manufacturing-controls</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-advances-thykaminetm-patent-strategy-with-proprietary-fingerprint-and-robust-manufacturing-controls</guid>
<pubDate>Tue, 17 Feb 2026 14:00:00 GMT</pubDate>
<description>Devonian Advances Thykamine&#x2122; Patent Strategy with Proprietary Fingerprint and Robust Manuf...</description>
</item>
<item>
<title>Devonian reports additional molecular data from MASH liver study</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-additional-molecular-data-140000609</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-additional-molecular-data-140000609</guid>
<pubDate>Thu, 12 Feb 2026 14:00:00 GMT</pubDate>
<description>Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD) (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to fibroinflammatory diseases, today announced additional preclinical results from its previously reported STAMTM mouse model in vivo study of metabolic dysfunction–associated steatohepatitis (MASH). These new data provide gene expression evidence supporting the anti-MASH, anti-inflammatory and anti-fibrotic effects of Thykamine™ observed in the</description>
</item>
<item>
<title>DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-positive-results-pulmonary-140000102</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-reports-positive-results-pulmonary-140000102</guid>
<pubDate>Tue, 10 Feb 2026 14:00:00 GMT</pubDate>
<description>Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to fibroinflammatory diseases, today announced a potential expanded therapeutic application for Thykamine™, with compelling preclinical data results demonstrating proof of concept efficacy in a well-established animal model of pulmonary fibrosis.</description>
</item>
<item>
<title>DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-appoints-dennis-turpin-as-chief-financial-officer-and-provides-updates-on-stock-options-grant</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-appoints-dennis-turpin-as-chief-financial-officer-and-provides-updates-on-stock-options-grant</guid>
<pubDate>Mon, 02 Feb 2026 13:45:00 GMT</pubDate>
<description>DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS ...</description>
</item>
<item>
<title>DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-announces-share-consolidation-in-further-preparation-for-potential-us-listing</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-announces-share-consolidation-in-further-preparation-for-potential-us-listing</guid>
<pubDate>Tue, 20 Jan 2026 14:00:00 GMT</pubDate>
<description>DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING ...</description>
</item>
<item>
<title>Devonian Health Group Announces Grant of Stock Options</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-grant-of-stock-options</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-grant-of-stock-options</guid>
<pubDate>Fri, 19 Dec 2025 14:15:00 GMT</pubDate>
<description>Devonian Health Group Announces Grant of Stock Options Canada NewsWire QUEBEC , ...</description>
</item>
<item>
<title>Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-financial-results-of-its-first-quarter-ended-on-october-31-2025-and-provides-corporate-update</guid>
<pubDate>Fri, 12 Dec 2025 13:45:00 GMT</pubDate>
<description>Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 an...</description>
</item>
<item>
<title>Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine(TM) as a Promising New Anti-Inflammatory Agent</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykaminetm-as-a-promising-new-anti-inflammatory-agent</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-publication-of-landmark-study-highlighting-thykaminetm-as-a-promising-new-anti-inflammatory-agent</guid>
<pubDate>Thu, 04 Dec 2025 13:45:00 GMT</pubDate>
<description>Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine&#x2122; as a...</description>
</item>
<item>
<title>Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-publication-134500676</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-publication-134500676</guid>
<pubDate>Thu, 04 Dec 2025 13:45:00 GMT</pubDate>
<description>Devonian Health Group Inc. ("Devonian" or the "Corporation") (TSXV: GSD) (OTCQB: DVHGF), a biopharmaceutical corporation specializing in the development of prescription drugs targeting fibroinflammatory diseases, is pleased to announce the publication of a peer-reviewed article in Biomedicines titled "Thykamine™: A New Player in the Field of Anti-Inflammatory Drugs." The study presents notable evidence supporting the potent multi-target anti-inflammatory properties of Thykamine™, the Corporation</description>
</item>
<item>
<title>Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-its-fourth-quarter-and-annual-2025-financial-results-and-appointment-of-a-new-board-member</guid>
<pubDate>Wed, 26 Nov 2025 17:01:00 GMT</pubDate>
<description>Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointmen...</description>
</item>
<item>
<title>Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Placement of Units</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-inc-announces-its-participation-to-the-thinkequity-conference-in-new-york-and-closing-of-a-non-brokered-private-placement-of-units</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-inc-announces-its-participation-to-the-thinkequity-conference-in-new-york-and-closing-of-a-non-brokered-private-placement-of-units</guid>
<pubDate>Thu, 23 Oct 2025 00:00:00 GMT</pubDate>
<description>Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York ...</description>
</item>
<item>
<title>Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-provides-corporate-update-and-additional-information-regarding-its-previously-announced-private-placement</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-provides-corporate-update-and-additional-information-regarding-its-previously-announced-private-placement</guid>
<pubDate>Fri, 22 Aug 2025 20:05:00 GMT</pubDate>
<description>Devonian Health Group Inc. (&#x201C; Devonian &#x201D; or the &#x201C; Corporation &#x201...</description>
</item>
<item>
<title>Devonian Announces Closing of a Private Placement of Units</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-announces-closing-of-a-private-placement-of-units</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-announces-closing-of-a-private-placement-of-units</guid>
<pubDate>Fri, 08 Aug 2025 00:00:00 GMT</pubDate>
<description>Not for distribution to United States newswire services or for dissemination in the United States...</description>
</item>
<item>
<title>Devonian Health Group Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-third-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-third-quarter-2025-financial-results</guid>
<pubDate>Thu, 26 Jun 2025 20:01:00 GMT</pubDate>
<description>Third quarter revenues increased 36% compared to 3Q24 Third quarter net loss of $0.03...</description>
</item>
<item>
<title>Devonian Appoints New Officers and Announces Grant of Stock Options</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-appoints-new-officers-and-announces-grant-of-stock-options</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-appoints-new-officers-and-announces-grant-of-stock-options</guid>
<pubDate>Mon, 09 Jun 2025 22:57:00 GMT</pubDate>
<description>Devonian Health Group Inc. (&#x201C; Devonian &#x201D; or the &#x201C; Corporation &#x201...</description>
</item>
<item>
<title>Canadian Investment Regulatory Organization Trade Resumption - GSD</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/canadian-investment-regulatory-organization-trade-resumption-gsd</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/canadian-investment-regulatory-organization-trade-resumption-gsd</guid>
<pubDate>Tue, 29 Apr 2025 20:20:00 GMT</pubDate>
<description>Canadian Investment Regulatory Organization Trade Resumption - GSD Canada NewsWire ...</description>
</item>
<item>
<title>Devonian Health Group Announces Reinstatement of Quotation on the TSXV</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-reinstatement-of-quotation-on-the-tsxv</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-announces-reinstatement-of-quotation-on-the-tsxv</guid>
<pubDate>Mon, 28 Apr 2025 20:00:00 GMT</pubDate>
<description>Devonian Health Group Inc. (&#x201C; Devonian &#x201D; or the &#x201C; Company &#x201D;) ...</description>
</item>
<item>
<title>Devonian Health Group Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-second-quarter-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/devonian-health-group-inc/news/devonian-health-group-reports-second-quarter-2025-financial-results</guid>
<pubDate>Tue, 15 Apr 2025 20:16:00 GMT</pubDate>
<description>Second quarter revenue increased 275% year over year Second quarter net loss of $0.00...</description>
</item>
</channel>
</rss>